1673-5269
2009 Issue 23
..............page:1905
Clinical research of radiosensitization by CMNa on nasopharyngeal carcinoma of stage ⅣB
LONG Bin;WANG Ying;JIANG Yong Department of Radiotherapy;Chongqing Cancer Hospital;Chongqing 400030;P.R.China
LONG Bin;WANG Ying;JIANG Yong Department of Radiotherapy;Chongqing Cancer Hospital;Chongqing 400030;P.R.China
..............page:1870-1871
Expressions of p53,c-erbB-2 and EGFR in linear gradient surgical margins of oral squamous cell carcinoma and their significance
XU Jia-jie1;3;GE Ming-hua1;ZHU Xin2;TAN Zhuo1;LING Zhi-qiang21.Department of Head and Neck Surgery;Zhejiang Cancer Hospital;Hangzhou 310022;P.R.China2.Zhejiang Cancer Research Institute;Hangzhou 310022;P.R.China3.Department of Stomatology;Medical College of Zhejiang University;Hangzhou 310006;P.R.China
XU Jia-jie1;3;GE Ming-hua1;ZHU Xin2;TAN Zhuo1;LING Zhi-qiang21.Department of Head and Neck Surgery;Zhejiang Cancer Hospital;Hangzhou 310022;P.R.China2.Zhejiang Cancer Research Institute;Hangzhou 310022;P.R.China3.Department of Stomatology;Medical College of Zhejiang University;Hangzhou 310006;P.R.China
..............page:1848-1851
Effects of Suppression of Survivin by YC-1 on apoptosis and proliferation of Eca109 and SGC-7901 cell lines
FENG Ya-dong;ZHU Hong;HAO Bo;SHI Rui-hua Department of Gastroenterology;First Affiliated Hospital of Nanjing Medical University;Nanjing 210029;P.R.China
FENG Ya-dong;ZHU Hong;HAO Bo;SHI Rui-hua Department of Gastroenterology;First Affiliated Hospital of Nanjing Medical University;Nanjing 210029;P.R.China
..............page:1836-1839,1843
Regulatory effect of subunits αv and β6 of integrin αvβ6 on proliferation and invasion of HO-8910PM cells
SONG Qu-qing;SHENG Xiu-gui;LI Qing-ju;MIAO Hua-qin;LI Qing-shui;LI Da-peng;ZHANG Xiao-ling Department of Gynecology;Shandong Cancer Hospital;Jinan 250117;P.R.China
SONG Qu-qing;SHENG Xiu-gui;LI Qing-ju;MIAO Hua-qin;LI Qing-shui;LI Da-peng;ZHANG Xiao-ling Department of Gynecology;Shandong Cancer Hospital;Jinan 250117;P.R.China
..............page:1844-1847
pei mei qu sai lian he bo lei zhou liao zhi liao wei ai gu ji gu sui zhuan yi yi li bao gao
zhu guang qing jin ying li de chang zhang yu zhen li wei min
zhu guang qing jin ying li de chang zhang yu zhen li wei min
..............page:1898-1900
Retrospective analysis of gemcitabine in combination with cisplatin therapty for advanced esophageal cancer patients
LI Pei;LIU Gang;LI Hong-yu;WANG Yan-rong Jilin Tumour Hospitol;Changchun 130012;P.R.China
LI Pei;LIU Gang;LI Hong-yu;WANG Yan-rong Jilin Tumour Hospitol;Changchun 130012;P.R.China
..............page:1887-1888
..............page:1904
..............page:1904
..............page:1903
Different SPECT/CT image registration methods using motion-phantom
ZHAO Zeng-jun1;2;LI Bao-sheng2;SUN Hong-fu2;WANG Zhong-tang2;YIN Yong2;LIU Tong-hai2;FU Zheng2;FANG Shou-xin21.Department of Radiation Oncology;Shandong University Qilu Hospital;Jinan 250012;P.R.China2.Shandong Tumor Hospital;Jinan 250117;P.R.China
ZHAO Zeng-jun1;2;LI Bao-sheng2;SUN Hong-fu2;WANG Zhong-tang2;YIN Yong2;LIU Tong-hai2;FU Zheng2;FANG Shou-xin21.Department of Radiation Oncology;Shandong University Qilu Hospital;Jinan 250012;P.R.China2.Shandong Tumor Hospital;Jinan 250117;P.R.China
..............page:1863-1866
..............page:1905
Combined determination of serum tumor marker and heat shock protein 60 for early gastric cancer diagnosis
MENG Qing-song;LI Xiang-dong;LI Xian-zhong;CHEN Zi-ping Department of Clinical Laboratory;Qianfoshan Hospital of Shandong Province;Jinan 250014;P.R.China
MENG Qing-song;LI Xiang-dong;LI Xian-zhong;CHEN Zi-ping Department of Clinical Laboratory;Qianfoshan Hospital of Shandong Province;Jinan 250014;P.R.China
..............page:1884-1886
Clinical effect of pemetrexed combined with oxaliplatin as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible
LI Tian Department of Respiratory Medicine Ⅱ;Nanjing Chest Hospital;Nanjing 210029;P.R.China
LI Tian Department of Respiratory Medicine Ⅱ;Nanjing Chest Hospital;Nanjing 210029;P.R.China
..............page:1889-1891
Expression of cyclooxygenase 2 in squamous cell carcinoma of tongue and tongue precancerous lesion
FAN Da-qing1;XIA He-shun1;WU Huan-ming21.Hubei Cancer Hospital;Wuhan 430079;P.R.China2.Department of Pathology;Tongji Medical College of Huazhong Science and Technology University;Wuhan 430030;P.R.China
FAN Da-qing1;XIA He-shun1;WU Huan-ming21.Hubei Cancer Hospital;Wuhan 430079;P.R.China2.Department of Pathology;Tongji Medical College of Huazhong Science and Technology University;Wuhan 430030;P.R.China
..............page:1825-1827
Random error and its clinical application in analyzing intensity modulated radiation therapy
WANG Jing1;ZHOU Zhi-xiao2;WANG Qi1;JIANG Ming-hua1;ZHAI Zhen-yu11.Department of Radiation Oncology;Jiangsu Cancer Hospital;Nanjing 210009;P.R.China2.Department of Radiation Oncology;Shanghai Xinhua Hospital;Shanghai 200030;P.R.China
WANG Jing1;ZHOU Zhi-xiao2;WANG Qi1;JIANG Ming-hua1;ZHAI Zhen-yu11.Department of Radiation Oncology;Jiangsu Cancer Hospital;Nanjing 210009;P.R.China2.Department of Radiation Oncology;Shanghai Xinhua Hospital;Shanghai 200030;P.R.China
..............page:1867-1869
Positron emission tomography for diagnosis and staging of advanced esophagus carcinoma
ZHANG Jian-dong1;YU Jin-ming2;GUO Hong-bo2;XING Li-gang2;CAO Cui-juan31.Department of Radiation Oncology;Affiliated Qianfoshan Hospital of Shandong University;Jinan 250000;P.R.China2.Shangdong Tumor Hospital;Jinan 250117;P.R.China3.Department of Radiation Oncology;Affiliated Jinxiang Hospital of Jining Medical College;Jining 272204;P.R.China
ZHANG Jian-dong1;YU Jin-ming2;GUO Hong-bo2;XING Li-gang2;CAO Cui-juan31.Department of Radiation Oncology;Affiliated Qianfoshan Hospital of Shandong University;Jinan 250000;P.R.China2.Shangdong Tumor Hospital;Jinan 250117;P.R.China3.Department of Radiation Oncology;Affiliated Jinxiang Hospital of Jining Medical College;Jining 272204;P.R.China
..............page:1875-1877
Clinical research on blood glucose following cisplatin-based cheomtherapy in non-small cell lung cancer patients
LI Jian-peng1;ZHU Zhi-tu1;GONG Ke-ting2;XING Yong-da1;YU Yun-long1;HA Min-wen11.Department of Oncology;First Affiliated Hospital of Liaoning Medical University;Jinzhou 121001;P.R.China2.Xintai City Family Planning Service Station;Taian 271200;P.R.China
LI Jian-peng1;ZHU Zhi-tu1;GONG Ke-ting2;XING Yong-da1;YU Yun-long1;HA Min-wen11.Department of Oncology;First Affiliated Hospital of Liaoning Medical University;Jinzhou 121001;P.R.China2.Xintai City Family Planning Service Station;Taian 271200;P.R.China
..............page:1878-1880
Targeted biodistribution of carboplatin-C Fe nanocage-loaded chitosan nanoparticles in rats with transplanted liver cancer
GUO Yue-hua1;YAN Wen-hui1;GUI Ling2;PANG Xue-bin1;LI Fu-rong1;BAO Shi-yun1;ZHOU Han-xin11.Department of Hepatobiliary Surgery;Shenzhen People’s Hospital;Second Clinical Medicine College of Jinan University;Shenzhen 518020;P.R.China2.Department of Pharmacy;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;Wuhan 430030;P.R.China
GUO Yue-hua1;YAN Wen-hui1;GUI Ling2;PANG Xue-bin1;LI Fu-rong1;BAO Shi-yun1;ZHOU Han-xin11.Department of Hepatobiliary Surgery;Shenzhen People’s Hospital;Second Clinical Medicine College of Jinan University;Shenzhen 518020;P.R.China2.Department of Pharmacy;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;Wuhan 430030;P.R.China
..............page:1828-1831
Inhibition effects of integrin αvβ6 siRNA on invasiveness of human ovarian cancer cells in vitro and in vivo
DU Xue-lian;SHENG Xiu-gui;SONG Qu-qing;WEI Ping;ZHANG Xiao-ling;LU Chun-hua Department of Gynecologic Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
DU Xue-lian;SHENG Xiu-gui;SONG Qu-qing;WEI Ping;ZHANG Xiao-ling;LU Chun-hua Department of Gynecologic Oncology;Shandong Cancer Hospital;Jinan 250117;P.R.China
..............page:1832-1835
Mechanism of apoptosis of lung adenocarcinoma cells induced by doxorubicin
ZHANG Ji-xian1;ZHAO Ying1;ZHANG Qi-kun21.Department of Respiratory;Yuyao People’s Hospital;Yuyao 315400;P.R.China2.Department of Respiratory;Second Hospital of Lanzhou University;Lanzhou 730030;P.R.China
ZHANG Ji-xian1;ZHAO Ying1;ZHANG Qi-kun21.Department of Respiratory;Yuyao People’s Hospital;Yuyao 315400;P.R.China2.Department of Respiratory;Second Hospital of Lanzhou University;Lanzhou 730030;P.R.China
..............page:1840-1843
Expression of cytokeratin 19 in peripheral blood of breast cancer patient and its clinical significance
TONG Qian1;DONG Xiu-ling1;GAO Ya-jie21.Department of Oncology;Dalian Third People’s Hospital;Dalian 116037;P.R.China2.Department of Oncology;First Affiliated Hospital of Dalian Medical University Dalian 116011;P.R.China
TONG Qian1;DONG Xiu-ling1;GAO Ya-jie21.Department of Oncology;Dalian Third People’s Hospital;Dalian 116037;P.R.China2.Department of Oncology;First Affiliated Hospital of Dalian Medical University Dalian 116011;P.R.China
..............page:1852-1853,1874
Clinical analysis of postoperative chemotherapy on patients with high-risk early stage endometrial cancer
DING Yin-hua1;MA Yue-bing21.Department of Gynaecology;Maternal and Child care Hospital;Laiyang 265200;P.R.China2.Department of Gynaecology;Shandong Tumor Hospital;Jinan 250117;P.R.China
DING Yin-hua1;MA Yue-bing21.Department of Gynaecology;Maternal and Child care Hospital;Laiyang 265200;P.R.China2.Department of Gynaecology;Shandong Tumor Hospital;Jinan 250117;P.R.China
..............page:1892-1893
Expressions of DR4 and Bax and their clinical significance in cervical carcinoma tissues
DU Jian-ying1;ZHONG Wei-bin2;LI Xu-hua1;TIAN Qing1;WANG Li-li11.Department of Gynaecology and Obstetrics;Weihai Women and Children’s Hospital;Weihai 264200;P.R.China2.Department of Cardiovascular;Weihai People’s Hospital;Weihai 264200;P.R.China
DU Jian-ying1;ZHONG Wei-bin2;LI Xu-hua1;TIAN Qing1;WANG Li-li11.Department of Gynaecology and Obstetrics;Weihai Women and Children’s Hospital;Weihai 264200;P.R.China2.Department of Cardiovascular;Weihai People’s Hospital;Weihai 264200;P.R.China
..............page:1860-1862
Quantitative analysis of volatile biomarkers in breath of non-small cell lung cancer patients
LIU Hu;SONG Geng;QIN Tao;PAN Yue-yin;XIONG Fu-xing;GU Kang-sheng;SUN Guo-ping;CHEN Zhen-dong Department of Oncology;First Affiliated Hospital of Anhui Medical University;Hefei 230022;P.R.China
LIU Hu;SONG Geng;QIN Tao;PAN Yue-yin;XIONG Fu-xing;GU Kang-sheng;SUN Guo-ping;CHEN Zhen-dong Department of Oncology;First Affiliated Hospital of Anhui Medical University;Hefei 230022;P.R.China
..............page:1857-1859
Evaluation and Comparative prognostic analysis of neoadjuvant chemotherapy on triple negative breast cancer
GAO Xing;NIE Kui;XU Dao-qun;HUANG Huai-an Department of Chemotherapy;Tumor Hospital of Huainan East Hospital Group;Huainan 232001;P.R.China
GAO Xing;NIE Kui;XU Dao-qun;HUANG Huai-an Department of Chemotherapy;Tumor Hospital of Huainan East Hospital Group;Huainan 232001;P.R.China
..............page:1872-1874
Clinical observation of gefitinib in treatment of advanced non-small cell lung cancer patients and analysis of influencing factors
LI Xiao-rui;CUI Yan-hui;ZHANG Qing-qin;HUA Qin-liang Department of Oncology;First Affiliated Hospital of Xinxiang Medical University;Weihui 453100;P.R.China
LI Xiao-rui;CUI Yan-hui;ZHANG Qing-qin;HUA Qin-liang Department of Oncology;First Affiliated Hospital of Xinxiang Medical University;Weihui 453100;P.R.China
..............page:1881-1883
Expressions of Survivin gene mRNA and its protein in esophageal squamous carcinoma tissues and their significance
LIU Hong-qi;SONG Shu Yancheng First People’s Hospital;Yancheng 224001;P.R.China
LIU Hong-qi;SONG Shu Yancheng First People’s Hospital;Yancheng 224001;P.R.China
..............page:1854-1856
..............page:1906
Progress of using protein chip in selecting tumor markers
CHEN Jin-guang;LIU Chi-bo;CHEN Xin Department of Dermatology;Taizhou Municipal Hospital;Taizhou 318000;P.R.China
CHEN Jin-guang;LIU Chi-bo;CHEN Xin Department of Dermatology;Taizhou Municipal Hospital;Taizhou 318000;P.R.China
..............page:1894-1897
..............page:1901-1902
Expression and significance of epidermal growth factor receptor variant Ⅲ in human esophageal carcinoma tissues
LIU Min1;GUO Xiao-juan1;GUO You-min2;DUAN Xiao-yi21.Department of Radiology;Beijing Chaoyang Hospital;Capital Medical University;Beijing 100020;P.R.China2.Imaging Center;First Affiliated Hospital;Medical College of Xi’an Jiaotong University;Xi’an 710069;P.R.China
LIU Min1;GUO Xiao-juan1;GUO You-min2;DUAN Xiao-yi21.Department of Radiology;Beijing Chaoyang Hospital;Capital Medical University;Beijing 100020;P.R.China2.Imaging Center;First Affiliated Hospital;Medical College of Xi’an Jiaotong University;Xi’an 710069;P.R.China
..............page:1821-1824